University of Tennessee College of Medicine

RedHill Announces FDA sNDA Approval for Talicia®

Retrieved on: 
Monday, September 18, 2023

RALEIGH, N.C. and TEL-AVIV, Israel, Sept. 18, 2023 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announced the U.S. Food and Drug Administration's (FDA) approval of its supplemental new drug application (sNDA) for Talicia[3], allowing a change to a more flexible three times daily (TID), taken at least 4 hours apart with food, dosing regimen for H. pylori eradication. This differs from the previously approved dosing regimen (Q8H), which required dosing every eight hours with food, by enabling patients to follow a convenient "breakfast, lunch and dinner" dosing routine, which may support increased patient adherence and optimize the potential for successful H. pylori eradication.

Key Points: 
  • "H. pylori treatment can be challenging for patients as most regimens require different pills to be taken multiple times per day.
  • "This new dosing regimen further supports the value of Talicia as an empirically prescribed first-line therapy for H. pylori eradication.
  • "Talicia is unique in that it is the only FDA-approved rifabutin-based therapy for the eradication of H. pylori.
  • "RedHill is committed to advancing GI and infectious disease management through patient-focused innovation.

Provectus Biopharmaceuticals Establishes Research Collaboration with University of Tennessee College of Veterinary Medicine to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal Sodium for Canine Soft Tissue Sarcomas

Retrieved on: 
Wednesday, June 28, 2023

UTCVM’s lead principal investigator of this work is clinical pathologist, comparative cancer biologist, and Assistant Professor Nora Springer, DVM, PhD, DACVP.

Key Points: 
  • UTCVM’s lead principal investigator of this work is clinical pathologist, comparative cancer biologist, and Assistant Professor Nora Springer, DVM, PhD, DACVP.
  • Soft tissue sarcomas are common malignant neoplasms in dogs that are locally invasive and have a high prevalence of recurrence after surgical excision.
  • Adjuvant chemotherapeutic protocols do not improve either time to recurrence or overall survival with incompletely excised soft tissue sarcomas.
  • Therefore, intralesional injection resulting in tumor ablation may be an ideal treatment modality for soft tissue sarcomas.

Allegheny Health Network Names Akshay Khandelwal, MD, System Chair of the Department of Cardiovascular Medicine

Retrieved on: 
Thursday, June 15, 2023

PITTSBURGH, June 15, 2023 /PRNewswire-PRWeb/ -- Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network (AHN).

Key Points: 
  • Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network.
  • PITTSBURGH, June 15, 2023 /PRNewswire-PRWeb/ -- Akshay Khandelwal, MD, MBA, FACC, FSCAI, an interventional cardiologist and physician leader with the Henry Ford Health system, has been named Chair of the Department of Cardiovascular Medicine at Allegheny Health Network (AHN).
  • The Department of Cardiovascular Medicine is part of AHN's Cardiovascular Institute.
  • "It's an incredible honor to join a forward thinking, blended health organization like AHN and Highmark Health that is truly committed to transforming medicine," Dr. Khandelwal said.

Urology Care Foundation Announces Recipients of Humanitarian Grant Program

Retrieved on: 
Tuesday, May 3, 2022

BALTIMORE, May 3, 2022 /PRNewswire/ --The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce the 2022 Urology Care Foundation Humanitarian Grant recipients.

Key Points: 
  • BALTIMORE, May 3, 2022 /PRNewswire/ --The Urology Care Foundation, the world's leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce the 2022 Urology Care Foundation Humanitarian Grant recipients.
  • As one of the world's largest urology-specific humanitarian-focused grant programs, the Urology Care Foundation Humanitarian Grant supports the efforts of individuals and projects providing direct urologic patient care to people and communities in underserved areas, either within the United States or abroad.
  • Learn more about the Urology Care Foundation Humanitarian Grant Program and the work of the 2022 grant recipients.
  • About the Urology Care Foundation:The Urology Care Foundation is the world's leading nonprofit urological health foundation, and the official foundation of the American Urological Association.

New Publications Highlight Impact of Companion Animals on Loneliness During the Pandemic

Retrieved on: 
Wednesday, October 6, 2021

The papers focus on the role of human-animal interaction (HAI) in helping to alleviate loneliness and social isolation during the pandemic.

Key Points: 
  • The papers focus on the role of human-animal interaction (HAI) in helping to alleviate loneliness and social isolation during the pandemic.
  • These papers were authored by working group members of the Consortium on Social Isolation and Companion Animals, established by HABRI and Mars Petcare in 2018.
  • "These publications represent a critical aspect of our Consortium effort to explore the potential of companion animals to help address the epidemic of loneliness and social isolation, which has only grown more pressing since the pandemic began," said Steven Feldman, president of HABRI.
  • In May 2019, HABRI and Mars co-hosted the first-ever Summit on Social Isolation and Companion Animals in Washington, DC.

St. Elizabeth's Medical Center Becomes a Boston University Teaching Hospital

Retrieved on: 
Monday, May 3, 2021

"\n"I am very pleased with the new affiliation between St. Elizabeth\'s Medical Center and our Medical School," Boston University President Robert A.

Key Points: 
  • "\n"I am very pleased with the new affiliation between St. Elizabeth\'s Medical Center and our Medical School," Boston University President Robert A.
  • "\nThe new partnership between St. Elizabeth\'s Medical Center and Boston University School of Medicine two nationally ranked institutions expands medical education programs at the hospital and gives additional resources to physicians, including teaching opportunities and broader research collaboration.
  • As a result of the partnership, the hospital will be rebranded as "St. Elizabeth\'s Medical Center, A Boston University Teaching Hospital.
  • Elizabeth\'s Medical Center, a Boston University Teaching Hospital, offers patients access to some of Boston\'s most respected physicians and advanced treatments for a full-range of medical specialties, including family medicine, cardiovascular care, women and infants\' health, cancer care, neurology care, and orthopedics.

World Renowned Pediatric Rheumatologist and Immunologist Terri Finkel, M.D., Ph.D. Joins Le Bonheur Children's Hospital, St. Jude Children's Research Hospital and The University of Tennessee Health Science Center

Retrieved on: 
Thursday, May 7, 2020

Dr. Finkel will lead clinical, administrative, research and educational efforts at UTHSC in collaboration with Le Bonheur.

Key Points: 
  • Dr. Finkel will lead clinical, administrative, research and educational efforts at UTHSC in collaboration with Le Bonheur.
  • She will work at St. Jude to expand and manage partnerships with UTHSC and Le Bonheur Children's, facilitating joint visioning for programmatic growth.
  • "At Le Bonheur Children's, we are very excited to have Dr. Terri Finkel on board," said Le Bonheur Children's President and CEO Michael Wiggins, MBA, FACHE.
  • Richard S. Finkel, M.D., a pediatric neurologist married to Terri Finkel, will also join St. Jude, UTHSC and Le Bonheur Children's.

QualDerm Partners Expands Its Network of Dermatology Practices in Tennessee

Retrieved on: 
Tuesday, May 22, 2018

"We're honored that Lebanon Dermatology has joined our network of affiliated practices," says Bill Southwick, Chief Executive Officer of QualDerm.

Key Points: 
  • "We're honored that Lebanon Dermatology has joined our network of affiliated practices," says Bill Southwick, Chief Executive Officer of QualDerm.
  • Under the partnership agreement, QualDerm will provide Lebanon Dermatology with management support, guidance and capital to expand their services.
  • QualDerm affiliated practices are located in Tennessee, North Carolina, South Carolina, Virginia, and Ohio.
  • Lebanon Dermatology was founded by Charles A. Mitchell, MD, who earned his medical degree from the University of Tennessee College of Medicine.